<mxfile host="app.diagrams.net" modified="2024-12-01T00:00:00.000Z" agent="5.0" version="24.0.0" etag="xyz" type="device">
  <diagram name="Virga-Gonadal-Hormones" id="virga-main">
    <mxGraphModel dx="2200" dy="1800" grid="1" gridSize="10" guides="1" tooltips="1" connect="1" arrows="1" fold="1" page="1" pageScale="1" pageWidth="1600" pageHeight="1800" math="0" shadow="0">
      <root>
        <mxCell id="0"/>
        <mxCell id="1" parent="0"/>

        <!-- TITLE -->
        <mxCell id="title" value="MEDICINAL CHEMISTRY - Dr. Virga&lt;br&gt;Gonadal Hormones | Estrogens | Progestins | Androgens | SERMs" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#e1d5e7;strokeColor=#9673a6;fontStyle=1;fontSize=18;align=center;verticalAlign=middle;" parent="1" vertex="1">
          <mxGeometry x="40" y="20" width="1520" height="80" as="geometry"/>
        </mxCell>

        <!-- SECTION 1: BIOSYNTHESIS PATHWAY -->
        <mxCell id="bio-section" value="SECTION 1: STEROID HORMONE BIOSYNTHESIS PATHWAY" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#d5e8d4;strokeColor=#82b366;fontStyle=1;fontSize=16;" parent="1" vertex="1">
          <mxGeometry x="40" y="130" width="1500" height="50" as="geometry"/>
        </mxCell>

        <mxCell id="cholesterol" value="Cholesterol" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#d5f5d5;strokeColor=#82b366;fontSize=12;fontStyle=1;" parent="1" vertex="1">
          <mxGeometry x="60" y="210" width="110" height="50" as="geometry"/>
        </mxCell>

        <mxCell id="pregnenolone" value="Pregnenolone" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#d5f5d5;strokeColor=#82b366;fontSize=12;fontStyle=1;" parent="1" vertex="1">
          <mxGeometry x="200" y="210" width="110" height="50" as="geometry"/>
        </mxCell>

        <mxCell id="progesterone" value="Progesterone&lt;br&gt;(C21)" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#f8cecc;strokeColor=#b85450;fontSize=12;fontStyle=1;" parent="1" vertex="1">
          <mxGeometry x="340" y="210" width="110" height="50" as="geometry"/>
        </mxCell>

        <mxCell id="testosterone" value="Testosterone&lt;br&gt;(C19)" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#dae8fc;strokeColor=#6c8ebf;fontSize=12;fontStyle=1;" parent="1" vertex="1">
          <mxGeometry x="480" y="210" width="110" height="50" as="geometry"/>
        </mxCell>

        <mxCell id="estradiol" value="Estradiol (E2)&lt;br&gt;(C18)" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#ffe6cc;strokeColor=#d79b00;fontSize=12;fontStyle=1;" parent="1" vertex="1">
          <mxGeometry x="620" y="210" width="110" height="50" as="geometry"/>
        </mxCell>

        <mxCell id="pathway-notes" value="Key Enzymes:&lt;br&gt;â€¢ CYP11A1 (side-chain cleavage)&lt;br&gt;â€¢ 3Î²-HSD (pregnenolone â†’ progesterone)&lt;br&gt;â€¢ 17,20-Lyase (C21 â†’ C19)&lt;br&gt;â€¢ Aromatase (CYP19): C19 â†’ C18&lt;br&gt;â€¢ 5Î±-Reductase: Testosterone â†’ DHT" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#d6b656;fontSize=11;align=left;" parent="1" vertex="1">
          <mxGeometry x="760" y="210" width="190" height="120" as="geometry"/>
        </mxCell>

        <!-- SECTION 2: ESTROGENS -->
        <mxCell id="estrogen-section" value="SECTION 2: ESTROGENS - Natural &amp; Synthetic" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#ffe6cc;strokeColor=#d79b00;fontStyle=1;fontSize=16;" parent="1" vertex="1">
          <mxGeometry x="40" y="370" width="750" height="50" as="geometry"/>
        </mxCell>

        <mxCell id="estradiol-sar" value="17Î²-Estradiol (E2) - SAR:&lt;br&gt;â€¢ C18 steroid&lt;br&gt;â€¢ AROMATIC A-RING (required)&lt;br&gt;â€¢ 3-OH phenolic (required)&lt;br&gt;â€¢ 17Î²-OH (required for max potency)&lt;br&gt;&lt;br&gt;Limitations:&lt;br&gt;â€¢ Poor oral bioavailability&lt;br&gt;â€¢ Rapid first-pass metabolism&lt;br&gt;â€¢ High SHBG binding" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#d79b00;fontSize=11;align=left;fontStyle=1;" parent="1" vertex="1">
          <mxGeometry x="60" y="450" width="180" height="175" as="geometry"/>
        </mxCell>

        <mxCell id="ee" value="Ethinyl Estradiol (EE):&lt;br&gt;â€¢ 17Î±-ethinyl group&lt;br&gt;â€¢ Blocks 17Î²-OH oxidation&lt;br&gt;â€¢ 15-20Ã— more potent orally&lt;br&gt;â€¢ Most common in COCs&lt;br&gt;&lt;br&gt;Mestranol:&lt;br&gt;â€¢ 3-O-methyl EE (prodrug)&lt;br&gt;â€¢ Requires O-demethylation" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#d79b00;fontSize=11;align=left;" parent="1" vertex="1">
          <mxGeometry x="260" y="450" width="160" height="155" as="geometry"/>
        </mxCell>

        <mxCell id="estradiol-esters" value="Estradiol Esters (IM):&lt;br&gt;â€¢ Valerate (17Î²-ester)&lt;br&gt;â€¢ Cypionate (17Î²-ester)&lt;br&gt;â€¢ Slow release (2-4 weeks)&lt;br&gt;â€¢ Depot formulations&lt;br&gt;â€¢ Overcome first-pass metabolism" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#d79b00;fontSize=11;align=left;" parent="1" vertex="1">
          <mxGeometry x="440" y="450" width="150" height="120" as="geometry"/>
        </mxCell>

        <mxCell id="conjugated-estrogens" value="Conjugated Estrogens (Premarin):&lt;br&gt;â€¢ Pregnant mare urine source&lt;br&gt;â€¢ Estrone sulfate&lt;br&gt;â€¢ Equilin (horse-specific)&lt;br&gt;â€¢ Equilenin (horse-specific)&lt;br&gt;&lt;br&gt;Use: Menopausal HRT" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#d79b00;fontSize=11;align=left;" parent="1" vertex="1">
          <mxGeometry x="610" y="450" width="160" height="130" as="geometry"/>
        </mxCell>

        <!-- SECTION 3: SERMs -->
        <mxCell id="serm-section" value="SECTION 3: SERMs - Selective Estrogen Receptor Modulators" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#ffe6cc;strokeColor=#d79b00;fontStyle=1;fontSize=16;" parent="1" vertex="1">
          <mxGeometry x="820" y="370" width="720" height="50" as="geometry"/>
        </mxCell>

        <mxCell id="tamoxifen-detail" value="Tamoxifen:&lt;br&gt;â€¢ Triphenylethylene core&lt;br&gt;â€¢ Z-isomer active&lt;br&gt;&lt;br&gt;Metabolism:&lt;br&gt;â€¢ CYP2D6 â†’ 4-OH-tamoxifen&lt;br&gt;  (100Ã— more potent)&lt;br&gt;â€¢ CYP3A4 â†’ N-desmethyl&lt;br&gt;&lt;br&gt;Tissue Effects:&lt;br&gt;â€¢ Breast: ANTAGONIST&lt;br&gt;â€¢ Endometrium: AGONIST (â†‘ cancer risk)&lt;br&gt;â€¢ Bone: AGONIST&lt;br&gt;&lt;br&gt;Use: ER+ breast cancer" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#d79b00;fontSize=11;align=left;fontStyle=1;" parent="1" vertex="1">
          <mxGeometry x="840" y="450" width="170" height="250" as="geometry"/>
        </mxCell>

        <mxCell id="raloxifene-detail" value="Raloxifene (Evista):&lt;br&gt;â€¢ Benzothiophene core&lt;br&gt;â€¢ Poor oral bioavailability (~5%)&lt;br&gt;â€¢ Extensive glucuronidation&lt;br&gt;&lt;br&gt;Tissue Effects:&lt;br&gt;â€¢ Breast: ANTAGONIST&lt;br&gt;â€¢ Uterus: ANTAGONIST (safer than tamoxifen)&lt;br&gt;â€¢ Bone: AGONIST&lt;br&gt;&lt;br&gt;Use:&lt;br&gt;â€¢ Postmenopausal osteoporosis&lt;br&gt;â€¢ Breast cancer prevention" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#d79b00;fontSize=11;align=left;fontStyle=1;" parent="1" vertex="1">
          <mxGeometry x="1030" y="450" width="170" height="235" as="geometry"/>
        </mxCell>

        <mxCell id="clomiphene-detail" value="Clomiphene (Clomid):&lt;br&gt;â€¢ E/Z isomer mixture&lt;br&gt;â€¢ Z-isomer: Estrogenic&lt;br&gt;â€¢ E-isomer: Antiestrogenic&lt;br&gt;&lt;br&gt;MOA for Infertility:&lt;br&gt;â€¢ Blocks ER in hypothalamus&lt;br&gt;â€¢ â†‘ GnRH secretion&lt;br&gt;â€¢ â†‘ FSH/LH release&lt;br&gt;â€¢ Induces ovulation&lt;br&gt;&lt;br&gt;Long tÂ½ (~5 days)" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#d79b00;fontSize=11;align=left;" parent="1" vertex="1">
          <mxGeometry x="1220" y="450" width="150" height="210" as="geometry"/>
        </mxCell>

        <mxCell id="ai-detail" value="Aromatase Inhibitors:&lt;br&gt;â€¢ Anastrozole (Arimidex)&lt;br&gt;â€¢ Letrozole (Femara)&lt;br&gt;&lt;br&gt;â€¢ Nonsteroidal triazoles&lt;br&gt;â€¢ N-4 nitrogen binds CYP19 heme&lt;br&gt;â€¢ Inhibit aromatase&lt;br&gt;â€¢ Block testosterone â†’ estrogen&lt;br&gt;â€¢ â†“ estradiol by 70-80%&lt;br&gt;&lt;br&gt;Use: Postmenopausal ER+ breast cancer&lt;br&gt;Side effects: Bone loss, joint pain" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#d79b00;fontSize=11;align=left;" parent="1" vertex="1">
          <mxGeometry x="1390" y="450" width="150" height="225" as="geometry"/>
        </mxCell>

        <!-- SECTION 4: PROGESTINS -->
        <mxCell id="progestin-section" value="SECTION 4: PROGESTINS - Natural &amp; Synthetic Generations" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#f8cecc;strokeColor=#b85450;fontStyle=1;fontSize=16;" parent="1" vertex="1">
          <mxGeometry x="40" y="740" width="1500" height="50" as="geometry"/>
        </mxCell>

        <mxCell id="progesterone-detail" value="Progesterone (Natural):&lt;br&gt;â€¢ C21 steroid&lt;br&gt;â€¢ 3-Keto, 4-ene (Î”4)&lt;br&gt;â€¢ 20-Keto&lt;br&gt;&lt;br&gt;Limitations:&lt;br&gt;â€¢ Rapid hepatic metabolism&lt;br&gt;â€¢ Poor oral bioavailability&lt;br&gt;&lt;br&gt;Synthetic modifications needed" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#b85450;fontSize=11;align=left;fontStyle=1;" parent="1" vertex="1">
          <mxGeometry x="60" y="820" width="170" height="165" as="geometry"/>
        </mxCell>

        <mxCell id="first-gen" value="1st Generation (Estranes):&lt;br&gt;â€¢ Norethindrone (NET)&lt;br&gt;â€¢ Norethindrone Acetate&lt;br&gt;â€¢ Ethynodiol Diacetate&lt;br&gt;&lt;br&gt;SAR:&lt;br&gt;â€¢ Remove C19 methyl&lt;br&gt;â€¢ Add 17Î±-ethinyl â†’ oral activity&lt;br&gt;â€¢ Some androgenic activity&lt;br&gt;â€¢ Metabolized to estrogenic compounds&lt;br&gt;&lt;br&gt;Use: Oral contraceptives, HRT" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#b85450;fontSize=11;align=left;" parent="1" vertex="1">
          <mxGeometry x="250" y="820" width="180" height="195" as="geometry"/>
        </mxCell>

        <mxCell id="second-gen" value="2nd Generation (Gonanes):&lt;br&gt;â€¢ Levonorgestrel (LNG)&lt;br&gt;â€¢ Desogestrel â†’ Etonogestrel&lt;br&gt;â€¢ Gestodene&lt;br&gt;â€¢ Norgestimate&lt;br&gt;&lt;br&gt;SAR:&lt;br&gt;â€¢ 13-Ethyl group (instead of 13-methyl)&lt;br&gt;â€¢ â†‘â†‘ Progestational potency&lt;br&gt;â€¢ LNG: Most androgenic in class&lt;br&gt;â€¢ Desogestrel/Gestodene: Lower androgenicity&lt;br&gt;&lt;br&gt;Use: Most common in COCs&lt;br&gt;LNG: Emergency contraception (Plan B)" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#b85450;fontSize=11;align=left;fontStyle=1;" parent="1" vertex="1">
          <mxGeometry x="450" y="820" width="210" height="240" as="geometry"/>
        </mxCell>

        <mxCell id="third-gen" value="3rd Generation:&lt;br&gt;â€¢ Drospirenone (Yasmin, Yaz)&lt;br&gt;&lt;br&gt;SAR:&lt;br&gt;â€¢ Spironolactone-derived&lt;br&gt;â€¢ Anti-mineralocorticoid (diuretic)&lt;br&gt;â€¢ Anti-androgenic (â†“ acne, hirsutism)&lt;br&gt;&lt;br&gt;Unique Properties:&lt;br&gt;â€¢ NO estrogenic activity&lt;br&gt;â€¢ NO androgenic activity&lt;br&gt;â€¢ NO glucocorticoid activity&lt;br&gt;&lt;br&gt;Use: COCs for PMDD, acne&lt;br&gt;Caution: Monitor Kâº" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#b85450;fontSize=11;align=left;fontStyle=1;" parent="1" vertex="1">
          <mxGeometry x="680" y="820" width="180" height="240" as="geometry"/>
        </mxCell>

        <mxCell id="fourth-gen" value="4th Generation:&lt;br&gt;â€¢ Dienogest&lt;br&gt;â€¢ Nestorone&lt;br&gt;&lt;br&gt;Properties:&lt;br&gt;â€¢ Ultra-selective PR agonists&lt;br&gt;â€¢ NO androgenic activity&lt;br&gt;â€¢ NO estrogenic activity&lt;br&gt;â€¢ NO glucocorticoid activity&lt;br&gt;â€¢ NO mineralocorticoid activity&lt;br&gt;&lt;br&gt;Use:&lt;br&gt;â€¢ Dienogest: Endometriosis&lt;br&gt;â€¢ Nestorone: Investigational (vaginal ring)" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#b85450;fontSize=11;align=left;" parent="1" vertex="1">
          <mxGeometry x="880" y="820" width="170" height="220" as="geometry"/>
        </mxCell>

        <mxCell id="progestin-antagonist" value="Progestin Antagonists/SPRMs:&lt;br&gt;&lt;br&gt;Mifepristone (RU-486):&lt;br&gt;â€¢ PR antagonist in uterus&lt;br&gt;â€¢ Also binds GR&lt;br&gt;â€¢ Long half-life&lt;br&gt;â€¢ Use: Medical abortion (+ misoprostol)&lt;br&gt;  Emergency contraception&lt;br&gt;&lt;br&gt;Ulipristal Acetate (Ella):&lt;br&gt;â€¢ SPRM (partial agonist/antagonist)&lt;br&gt;â€¢ Weak anti-androgen&lt;br&gt;â€¢ Use: Emergency contraception (up to 120 hr)&lt;br&gt;â€¢ More effective than LNG at 72-120h" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#f8cecc;strokeColor=#b85450;fontSize=11;align=left;fontStyle=1;" parent="1" vertex="1">
          <mxGeometry x="1070" y="820" width="210" height="250" as="geometry"/>
        </mxCell>

        <!-- SECTION 5: ANDROGENS -->
        <mxCell id="androgen-section" value="SECTION 5: ANDROGENS - Testosterone &amp; Anabolic Steroids" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#dae8fc;strokeColor=#6c8ebf;fontStyle=1;fontSize=16;" parent="1" vertex="1">
          <mxGeometry x="40" y="1110" width="1500" height="50" as="geometry"/>
        </mxCell>

        <mxCell id="testosterone-detail" value="Testosterone (Natural):&lt;br&gt;â€¢ C19 steroid&lt;br&gt;â€¢ 3-Keto, 4-ene&lt;br&gt;â€¢ 17Î²-OH&lt;br&gt;&lt;br&gt;Limitations:&lt;br&gt;â€¢ Not orally active&lt;br&gt;â€¢ Rapid first-pass metabolism&lt;br&gt;&lt;br&gt;Conversion:&lt;br&gt;â€¢ 5Î±-Reductase â†’ DHT (more potent)" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#b3d9ff;strokeColor=#6c8ebf;fontSize=11;align=left;fontStyle=1;" parent="1" vertex="1">
          <mxGeometry x="60" y="1190" width="170" height="175" as="geometry"/>
        </mxCell>

        <mxCell id="test-esters" value="Testosterone Esters (TRT):&lt;br&gt;â€¢ Propionate (short-acting)&lt;br&gt;â€¢ Enanthate (long-acting)&lt;br&gt;â€¢ Cypionate (long-acting)&lt;br&gt;&lt;br&gt;Properties:&lt;br&gt;â€¢ 17Î²-Esters&lt;br&gt;â€¢ IM injection&lt;br&gt;â€¢ Slow release (2-4 weeks)&lt;br&gt;â€¢ Overcome first-pass metabolism&lt;br&gt;&lt;br&gt;Use: Testosterone replacement therapy&lt;br&gt;Male hypogonadism" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#b3d9ff;strokeColor=#6c8ebf;fontSize=11;align=left;" parent="1" vertex="1">
          <mxGeometry x="250" y="1190" width="180" height="200" as="geometry"/>
        </mxCell>

        <mxCell id="alkylated" value="17Î±-Alkylated Androgens:&lt;br&gt;â€¢ 17Î±-Methyltestosterone&lt;br&gt;â€¢ Fluoxymesterone (9Î±-fluoro, 20Ã— potency)&lt;br&gt;&lt;br&gt;SAR:&lt;br&gt;â€¢ 17Î±-Alkyl group prevents metabolism&lt;br&gt;â€¢ Oral activity&lt;br&gt;â€¢ 9Î±-Fluoro increases potency 20-fold&lt;br&gt;&lt;br&gt;Issues:&lt;br&gt;â€¢ HEPATOTOXIC (liver damage)&lt;br&gt;â€¢ Cholestatic jaundice&lt;br&gt;â€¢ Sodium/water retention&lt;br&gt;â€¢ Limited clinical use due to toxicity" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#b3d9ff;strokeColor=#6c8ebf;fontSize=11;align=left;" parent="1" vertex="1">
          <mxGeometry x="450" y="1190" width="200" height="220" as="geometry"/>
        </mxCell>

        <mxCell id="anabolic" value="Anabolic Steroids (19-Norandrogens):&lt;br&gt;â€¢ Oxandrolone (Anavar)&lt;br&gt;â€¢ Oxymetholone (Anadrol)&lt;br&gt;â€¢ Stanozolol (Winstrol)&lt;br&gt;â€¢ Nandrolone Esters&lt;br&gt;&lt;br&gt;SAR:&lt;br&gt;â€¢ Remove C19 methyl â†’ â†“ androgenic effects&lt;br&gt;â€¢ Retain anabolic action (muscle growth)&lt;br&gt;â€¢ Various ring modifications&lt;br&gt;&lt;br&gt;Clinical Use:&lt;br&gt;â€¢ Muscle wasting (HIV, cancer cachexia)&lt;br&gt;â€¢ Osteoporosis&lt;br&gt;â€¢ Severe burns&lt;br&gt;&lt;br&gt;Abuse: Athletic performance, bodybuilding&lt;br&gt;Side effects: Liver damage, CV issues" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#b3d9ff;strokeColor=#6c8ebf;fontSize=11;align=left;fontStyle=1;" parent="1" vertex="1">
          <mxGeometry x="670" y="1190" width="230" height="265" as="geometry"/>
        </mxCell>

        <mxCell id="sarms" value="SARMs (Investigational):&lt;br&gt;â€¢ Enobosarm (Ostarine)&lt;br&gt;â€¢ Ligandrol (LGD-4033)&lt;br&gt;â€¢ S-23&lt;br&gt;â€¢ RAD-140&lt;br&gt;&lt;br&gt;Concept:&lt;br&gt;â€¢ Non-steroidal compounds&lt;br&gt;â€¢ Selective AR modulation&lt;br&gt;â€¢ Tissue-selective AR agonism&lt;br&gt;â€¢ Attempt to separate anabolic from&lt;br&gt;  androgenic effects&lt;br&gt;&lt;br&gt;Goals:&lt;br&gt;â€¢ â†‘ Muscle mass without prostate enlargement&lt;br&gt;â€¢ â†“ Androgenic side effects&lt;br&gt;&lt;br&gt;Status:&lt;br&gt;â€¢ NOT FDA-approved&lt;br&gt;â€¢ Banned in sports&lt;br&gt;â€¢ Long-term safety unknown" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#b3d9ff;strokeColor=#6c8ebf;fontSize=11;align=left;" parent="1" vertex="1">
          <mxGeometry x="920" y="1190" width="190" height="310" as="geometry"/>
        </mxCell>

        <!-- HIGH-YIELD PEARLS -->
        <mxCell id="pearls-section" value="HIGH-YIELD GONADAL HORMONE MED CHEM PEARLS" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#d6b656;fontStyle=1;fontSize=16;" parent="1" vertex="1">
          <mxGeometry x="40" y="1540" width="1500" height="50" as="geometry"/>
        </mxCell>

        <mxCell id="pearl1" value="ðŸ”¬ Aromatic A-ring:&lt;br&gt;ABSOLUTELY REQUIRED for estrogenic&lt;br&gt;activity (phenolic OH at C3)" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#ffe6cc;strokeColor=#d79b00;fontSize=11;fontStyle=1;align=center;" parent="1" vertex="1">
          <mxGeometry x="60" y="1610" width="180" height="70" as="geometry"/>
        </mxCell>

        <mxCell id="pearl2" value="ðŸ”¬ 17Î±-Ethinyl group:&lt;br&gt;Blocks 17Î²-OH oxidation&lt;br&gt;â†’ Enables oral activity (EE, NET)" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#ffe6cc;strokeColor=#d79b00;fontSize=11;fontStyle=1;align=center;" parent="1" vertex="1">
          <mxGeometry x="260" y="1610" width="180" height="70" as="geometry"/>
        </mxCell>

        <mxCell id="pearl3" value="ðŸ”¬ 13-Ethyl vs 13-Methyl:&lt;br&gt;Gonanes (13-ethyl) have dramatically&lt;br&gt;â†‘ progestational potency" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#ffe6cc;strokeColor=#d79b00;fontSize=11;fontStyle=1;align=center;" parent="1" vertex="1">
          <mxGeometry x="460" y="1610" width="180" height="70" as="geometry"/>
        </mxCell>

        <mxCell id="pearl4" value="ðŸ”¬ Remove C19:&lt;br&gt;Removing C19 methyl â†’ anabolic selectivity&lt;br&gt;(â†“ androgenic, retain muscle building)" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#ffe6cc;strokeColor=#d79b00;fontSize=11;fontStyle=1;align=center;" parent="1" vertex="1">
          <mxGeometry x="660" y="1610" width="180" height="70" as="geometry"/>
        </mxCell>

        <mxCell id="pearl5" value="ðŸ”¬ SERMs tissue selectivity:&lt;br&gt;Alter ER conformation â†’ differential&lt;br&gt;coactivator recruitment in different tissues" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#ffe6cc;strokeColor=#d79b00;fontSize=11;fontStyle=1;align=center;" parent="1" vertex="1">
          <mxGeometry x="860" y="1610" width="180" height="70" as="geometry"/>
        </mxCell>

        <mxCell id="pearl6" value="ðŸ”¬ Aromatase (CYP19):&lt;br&gt;Converts C19 androgens â†’ C18 estrogens&lt;br&gt;(Target for AIs in breast cancer)" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#ffe6cc;strokeColor=#d79b00;fontSize=11;fontStyle=1;align=center;" parent="1" vertex="1">
          <mxGeometry x="1060" y="1610" width="180" height="70" as="geometry"/>
        </mxCell>

        <mxCell id="pearl7" value="ðŸ”¬ Drospirenone uniqueness:&lt;br&gt;ONLY progestin with anti-mineralocorticoid&lt;br&gt;activity (diuretic effect, monitor Kâº)" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#ffe6cc;strokeColor=#d79b00;fontSize=11;fontStyle=1;align=center;" parent="1" vertex="1">
          <mxGeometry x="1260" y="1610" width="180" height="70" as="geometry"/>
        </mxCell>

        <mxCell id="pearl8" value="ðŸ”¬ 17Î±-Alkylation hepatotoxicity:&lt;br&gt;Oral androgens (17Î±-methyl) cause liver&lt;br&gt;damage â†’ Limited clinical use" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#ffe6cc;strokeColor=#d79b00;fontSize=11;fontStyle=1;align=center;" parent="1" vertex="1">
          <mxGeometry x="260" y="1700" width="180" height="60" as="geometry"/>
        </mxCell>

        <mxCell id="pearl9" value="ðŸ”¬ Tamoxifen metabolism:&lt;br&gt;CYP2D6 polymorphism affects 4-OH-tamoxifen&lt;br&gt;formation (100Ã— more potent metabolite)" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#ffe6cc;strokeColor=#d79b00;fontSize=11;fontStyle=1;align=center;" parent="1" vertex="1">
          <mxGeometry x="460" y="1700" width="180" height="60" as="geometry"/>
        </mxCell>

        <mxCell id="pearl10" value="ðŸ”¬ Progestin generations trend:&lt;br&gt;1st â†’ 4th gen: â†‘ selectivity, â†“ side effects&lt;br&gt;(less androgenic, better PR selectivity)" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#ffe6cc;strokeColor=#d79b00;fontSize=11;fontStyle=1;align=center;" parent="1" vertex="1">
          <mxGeometry x="660" y="1700" width="180" height="60" as="geometry"/>
        </mxCell>

        <!-- LEGEND -->
        <mxCell id="legend-title" value="LEGEND" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#f5f5f5;strokeColor=#666666;fontStyle=1;fontSize=12;" parent="1" vertex="1">
          <mxGeometry x="1130" y="1190" width="410" height="30" as="geometry"/>
        </mxCell>

        <mxCell id="legend1" value="Green = Biosynthesis pathway" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#d5e8d4;strokeColor=#82b366;fontSize=10;" parent="1" vertex="1">
          <mxGeometry x="1130" y="1235" width="190" height="30" as="geometry"/>
        </mxCell>

        <mxCell id="legend2" value="Orange = Estrogens &amp; SERMs" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#ffe6cc;strokeColor=#d79b00;fontSize=10;" parent="1" vertex="1">
          <mxGeometry x="1350" y="1235" width="190" height="30" as="geometry"/>
        </mxCell>

        <mxCell id="legend3" value="Pink = Progestins" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#f8cecc;strokeColor=#b85450;fontSize=10;" parent="1" vertex="1">
          <mxGeometry x="1130" y="1280" width="190" height="30" as="geometry"/>
        </mxCell>

        <mxCell id="legend4" value="Blue = Androgens" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#dae8fc;strokeColor=#6c8ebf;fontSize=10;" parent="1" vertex="1">
          <mxGeometry x="1350" y="1280" width="190" height="30" as="geometry"/>
        </mxCell>

        <mxCell id="legend5" value="Yellow = SAR/mechanism pearls" style="rounded=1;whiteSpace=wrap;html=1;fillColor=#fff2cc;strokeColor=#d6b656;fontSize=10;" parent="1" vertex="1">
          <mxGeometry x="1130" y="1325" width="410" height="30" as="geometry"/>
        </mxCell>

      </root>
    </mxGraphModel>
  </diagram>
</mxfile>
